These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 37423396)
1. Risk of Herpes Zoster Ophthalmicus After COVID-19 Vaccination in a Large US Health Care Claims Database. Akpandak I; Sechrist SJ; Miller DC; Sun Y; Arnold BF; Kelly JD; Acharya NR Am J Ophthalmol; 2024 Feb; 258():139-144. PubMed ID: 37423396 [TBL] [Abstract][Full Text] [Related]
3. Assessment of Herpes Zoster Risk Among Recipients of COVID-19 Vaccine. Akpandak I; Miller DC; Sun Y; Arnold BF; Kelly JD; Acharya NR JAMA Netw Open; 2022 Nov; 5(11):e2242240. PubMed ID: 36383382 [TBL] [Abstract][Full Text] [Related]
4. Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United States. Abara WE; Gee J; Marquez P; Woo J; Myers TR; DeSantis A; Baumblatt JAG; Woo EJ; Thompson D; Nair N; Su JR; Shimabukuro TT; Shay DK JAMA Netw Open; 2023 Feb; 6(2):e2253845. PubMed ID: 36723942 [TBL] [Abstract][Full Text] [Related]
5. Risk of Herpes Zoster Ophthalmicus Recurrence After Recombinant Zoster Vaccination. Walia A; Sun Y; Acharya NR JAMA Ophthalmol; 2024 Mar; 142(3):249-256. PubMed ID: 38358762 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness of the Recombinant Zoster Vaccine for Herpes Zoster Ophthalmicus in the United States. Lu A; Sun Y; Porco TC; Arnold BF; Acharya NR Ophthalmology; 2021 Dec; 128(12):1699-1707. PubMed ID: 33892049 [TBL] [Abstract][Full Text] [Related]
8. [Herpes Zoster Ophthalmicus after Pfizer BNT162b2 and Moderna mRNA-1273 vaccination in two young and immunocompetent patients]. Amblard MA; Costantini E; Hayek G; Ricaud X J Fr Ophtalmol; 2022 Nov; 45(9):1000-1003. PubMed ID: 36155145 [TBL] [Abstract][Full Text] [Related]
10. Risk of encephalitis and meningitis after COVID-19 vaccination in South Korea: a self-controlled case series analysis. Kim JH; Yoon D; Ko HY; Jung K; Sunwoo JS; Shin WC; Byun JI; Shin JY BMC Med; 2024 Mar; 22(1):123. PubMed ID: 38486297 [TBL] [Abstract][Full Text] [Related]
11. COVID-19 Vaccine-Associated Uveitis in Patients With a History of Uveitis. Kim J; Kwon HY; Ahn SJ JAMA Ophthalmol; 2024 Jun; 142(6):522-528. PubMed ID: 38662361 [TBL] [Abstract][Full Text] [Related]
12. A Case Report of Herpes Zoster Ophthalmicus and Meningitis After COVID-19 Vaccination. You IC; Ahn M; Cho NC J Korean Med Sci; 2022 May; 37(20):e165. PubMed ID: 35607743 [TBL] [Abstract][Full Text] [Related]
13. Incidence of Severe COVID-19 Illness Following Vaccination and Booster With BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines. Kelly JD; Leonard S; Hoggatt KJ; Boscardin WJ; Lum EN; Moss-Vazquez TA; Andino R; Wong JK; Byers A; Bravata DM; Tien PC; Keyhani S JAMA; 2022 Oct; 328(14):1427-1437. PubMed ID: 36156706 [TBL] [Abstract][Full Text] [Related]
14. Incidence Rate of Herpes Zoster Ophthalmicus: A Retrospective Cohort Study from 1994 through 2018. Kong CL; Thompson RR; Porco TC; Kim E; Acharya NR Ophthalmology; 2020 Mar; 127(3):324-330. PubMed ID: 31668889 [TBL] [Abstract][Full Text] [Related]
15. Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study. Wong CKH; Lau KTK; Xiong X; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Chan EWY; Gao L; Cheng FWT; Tang SCW; Wong ICK PLoS Med; 2022 Jun; 19(6):e1004018. PubMed ID: 35727759 [TBL] [Abstract][Full Text] [Related]
16. Risk of retinal vein occlusion following COVID-19 vaccination: a self-controlled case series. Pellegrini M; Carnevali A; Fiore T; Cagini C; De Palma A; Fontana L; Lupardi E; Cassini F; Bacherini D; Giansanti F; Giannaccare G; Scorcia V; Vaccaro S; Ciarmatori N; D'Angelo S; Parmeggiani F; Mura M Eye (Lond); 2023 Oct; 37(14):3000-3003. PubMed ID: 36813998 [TBL] [Abstract][Full Text] [Related]
17. Herpes zoster following BNT162b2 mRNA COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series. Furer V; Zisman D; Kibari A; Rimar D; Paran Y; Elkayam O Rheumatology (Oxford); 2021 Oct; 60(SI):SI90-SI95. PubMed ID: 33848321 [TBL] [Abstract][Full Text] [Related]
18. Herpes Zoster Reactivation After mRNA and Adenovirus-Vectored Coronavirus Disease 2019 Vaccination: Analysis of National Health Insurance Database. Yoon JG; Kim YE; Choi MJ; Choi WS; Seo YB; Jung J; Hyun HJ; Seong H; Nham E; Noh JY; Song JY; Kim WJ; Kim DW; Cheong HJ J Infect Dis; 2023 Nov; 228(10):1326-1335. PubMed ID: 37549237 [TBL] [Abstract][Full Text] [Related]
19. Dermatologic Reactions Following COVID-19 Vaccination: A Case Series. Alkanat HÖ; Kulaklı S Cutis; 2024 Feb; 113(2):E16-E19. PubMed ID: 38593110 [TBL] [Abstract][Full Text] [Related]